Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2025-12-30 @ 1:14 AM
Study NCT ID:
NCT00723658
Status:
WITHDRAWN
Last Update Posted:
2015-03-06
First Post:
2008-07-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia
Sponsor:
SWOG Cancer Research Network
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-09
Start Date Type:
None
Primary Completion Date:
2010-05
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2008-07-26
First Submit QC Date:
None
Study First Post Date:
2008-07-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-03-05
Last Update Post Date:
2015-03-06
Last Update Post Date Type:
ESTIMATED